Research Spotlight: Performance of clinician-assigned SCAI shock staging in a large multicenter registry of patients with cardiogenic shock
Berg, David
( Brigham and Womens Hospital
, Boston
, Massachusetts
, United States
)
Author Disclosures:
David Berg:DO have relevant financial relationships
;
Research Funding (PI or named investigator):AstraZenea:Active (exists now)
; Other (please indicate in the box next to the company name):CEC - CeleCor Therapeutics:Active (exists now)
; Other (please indicate in the box next to the company name):CEC - Beckman Coulter:Active (exists now)
; Other (please indicate in the box next to the company name):CEC - Novo Nordisk:Active (exists now)
; Other (please indicate in the box next to the company name):CEC - Tosoh Biosciences:Active (exists now)
; Other (please indicate in the box next to the company name):CEC - Kowa Pharmaceuticals:Past (completed)
; Speaker:USV Private Limited:Past (completed)
; Speaker:Pri-Med:Past (completed)
; Speaker:Metabolic Endocrine Education Foundation:Past (completed)
; Consultant:Youngene Therapeutics:Past (completed)
; Consultant:Pfizer:Active (exists now)
; Consultant:AstraZeneca:Active (exists now)
; Research Funding (PI or named investigator):Merck:Active (exists now)
; Research Funding (PI or named investigator):Pfizer:Active (exists now)